Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Headache. 2012 Feb;52(2):244–261. doi: 10.1111/j.1526-4610.2011.02031.x

Table 2.

Least-squares means and standard errors for all primary outcome measures over time for 185 participants

Control Experimental
Baseline
n=91
Post
n=87
3-month
n=73
6-month
n=74
Baseline
n=89
Post
n=68
3-month
n=51
6-month
n=46
Chronic Pain Coping Inventory
 Assistance 1.43(0.17) 1.42(0.18) 1.62(0.18) 1.58(0.20) 1.57(0.17) 1.81(0.19) 1.74(0.21) 1.66(0.23)
 Coping 2.19(0.22) 2.09(0.21) 2.09(0.22) 1.99(0.24) 2.38(0.22) 2.91(0.23) 2.92(0.25) 2.82(0.28)
 Exercise 1.66(0.17) 1.61(0.19) 2.01(0.21) 2.00(0.22) 1.55(0.17)a 2.44(0.21)a 2.48(0.24) 2.16(0.26)
 Persistence 2.46(0.17) 2.33(0.18) 2.28(0.21) 2.08(0.19) 2.07(0.18)ab 2.66(0.20)a 2.80(0.24)b 2.25(0.23)
 Resting 2.36(0.18) 2.11(0.17) 2.17(0.18) 2.18(0.21) 2.76(0.18) 2.96(0.19) 3.13(0.21) 2.55(0.24)
 Relaxation 1.36(0.15) 1.47(0.17) 1.60(0.19) 1.47(0.20) 1.46(0.15)abc 2.30(0.18)a 2.45(0.21)b 2.18(0.22)c
 Social 1.67(0.18) 1.25(0.18) 1.56(0.20) 1.46(0.20) 1.70(0.18)a 2.29(0.20)a 2.24(0.22) 2.11(0.23)
 Guarding 1.14(0.14) 1.05(0.14) 1.19(0.15) 1.38(0.17) 1.33(0.14) 1.28(0.15) 1.41(0.17) 1.16(0.20)
Depression/Anxiety/Stress Scale
 Anxiety 19.52(0.83) 19.85(0.76) 19.57(0.79) 19.39(0.85) 20.42(0.83) 18.89(0.80) 18.54(0.86) 18.66(0.99)
 Depression 21.38(0.97) 21.44(0.90) 21.40(0.84) 22.03(1.02) 22.77(0.98)ab 20.39(0.97) 18.63(0.94)a 19.67(1.21)b
 Stress 26.68(1.07) 26.66(0.96) 26.69(0.96) 25.21(1.08) 26.95(1.08)ab 24.10(1.02)a 23.09(1.06)b 22.79(1.28)
Headache Self-Efficacy Scale
 Total Score 108.80(2.08) 112.20(2.12) 114.74(2.60) 116.19(2.50) 103.21(2.10)abc 120.16(2.27)a 122.12(2.86)b 121.45(2.85)c
Headache-Specific Locus of Control
 Chance 35.26(0.98) 36.61(1.01) 36.63(1.05) 36.18(1.03) 33.74(0.99)a 36.41(1.07) 37.08(1.17) 38.97(1.17)a
 Health Care 34.55(0.81) 33.25(0.79) 34.29(0.85) 33.26(0.88) 33.93(0.82) 32.09(0.84) 32.72(0.93) 31.40(1.01)
  Professional Internal 35.29(0.99) 36.08(0.91) 36.92(1.02) 36.85(1.00) 35.27(0.99) 38.20(0.96) 37.72(1.12) 36.89(1.11)
MIDAS
 Total Score 51.60(4.74) 46.04(4.80) 42.54(5.25) 39.45(4.94) 48.66(4.78) 42.48(5.08) 42.17(5.79) 36.05(5.75)
Medication Safety Knowledge1
 Total Correct 6.13(0.19) 6.30(0.19) -- 6.49(0.18) 6.27(0.17) 6.10(0.20) -- 5.88(0.22)
Pain Catastrophizing Scale
 Helplessness 13.14(0.68) 12.67(0.62) 11.66(0.66) 11.56(0.60) 15.01(0.68)abc 11.99(0.66)a 11.10(0.74)b 10.31(0.70)c
 Magnification 6.02(0.30) 5.81(0.29) 5.34(0.28) 5.27(0.29) 6.50(0.31)a 5.44(0.31) 4.63(0.32)a 4.72(0.34)
 Rumination 11.09(0.49) 10.25(0.47) 9.44(0.49) 9.83(0.51) 11.93(0.50)ab 9.71(0.51) 8.34(0.57)a 7.61(0.60)b
 Total 30.25(1.35) 28.70(1.26) 26.41(1.34) 26.66(1.29) 33.44(1.36)abc 27.13(1.34)a 24.12(1.50)b 22.62(1.50)c
Patient Global Assessment of Change
 Improvement -- 3.56(0.09) 3.48(0.11) 3.34(0.12) -- 3.03(0.10) 2.60(0.13) 2.49(0.15)
1

Analysis limited to participants currently taking opioid medications (control n=57; experimental n=68; total n=125).

Shared subscripts on one line indicate significantly different post-hoc contrasts (Bonferroni-adjusted alpha=.0167)